Clinical study and follow-up of 100 patients with the antiphospholipid syndrome

Seminars in Arthritis and Rheumatism

Volumn 29, Issue 3, 1999, Pages 182-190

  Muoz Rodríguez, Francisco J ^a,c   Font, Josep ^a,c   Cervera, Richard ^a,c   Reverter, Joan Carles ^b,c   Tàssies, Dolors ^b,c   Espinosa, Gerard ^a,c   López Soto, Alfonso ^a,c   Carmona, Francisco ^b,c   Balasch, Joan ^a,c   Ordinas, Antoni ^b,c   Ingelmo, Miguel ^a,c  

^a Systemic Autoimmune Diseases Unit   (Spain)

^b Department OfHemotherapy and Hemostasis ^*  (Spain)

^c HOSPITAL CLÍNIC   (Spain)

Author keywords

Antiphospholipid syndrome; Obstetric complications; Prophylactic treatment; Thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTINUCLEAR ANTIBODY; COMPLEMENT;

ABORTION; ADULT; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; FEMALE; FOLLOW UP; HEMOLYTIC ANEMIA; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROPHYLAXIS; RECURRENT DISEASE; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTOPENIA; THROMBOSIS;

EID: 0033386110     PISSN: 00490172     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0049-0172(99)80029-8     Document Type: Article

References (39)

1. Khamashta M.A. Hughes G.R.V. Antiphospholipid antibodies and antiphospholipid syndrome Curr Opin Rheumatol 7 1995 389 394
2. Asherson R.A. Khamashta M.A. Ordi-Ros J. Derksen R.H. Machin S.J. Path F.R.C. The “primary” antiphospholipid syndrome: major clinical and serological features Medicine (Baltimore) 68 1989 366 374
3. Font J. Cervera R. López-Soto A. Pallarés L. Bosch X. Ampurdanés S. Anticardiolipin antibodies in patients with autoimmune diseases: isotype distribution and clinical associations Clin Rheumatol 8 1989 475 483
4. Cervera R. Khamashta M.A. Font J. Sebastiani G.D. Gil A. Lavilla P. Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in a cohort of 1000 patients Medicine (Baltimore) 72 1993 113 124
5. Roubey R.A.S. Immunology of the antiphospholipid antibody syndrome Arthritis Rheum 39 1996 1444 1454
6. Forastiero R.R. Martinuzzo M.E. Kordich L.C. Carreras L.O. Reactivity to beta-2-glycoprotein I clearly differentiates anticardiolipin antibodies from antiphospholipid syndrome and syphilis Thromb Haemost 75 1996 717 720
7. (Abstract) Harris E.N. Baguley E. Asherson R.A. Hughes G.R.V. Clinical and serological features of the antiphospholipid syndrome (APS) Br J Rheumatol 26 1987 19
8. Tan E.M. Cohen A.S. Fries J.F. Masi A.T. McShane D.J. Rothfield N.F. The 1982 revised criteria for the classification of systemic lupus erythematosus Arthritis Rheum 25 1982 1271 1277
9. Gharavi A.E. Harris E.N. Asherson R.A. Hughes G.R.V. Anticardiolipin antibodies: isotype distribution and phospholipid specificity Ann Rheum Dis 46 1987 1 6
10. Brandt J.T. Barna L.K. Triplett DA. Laboratory identification of lupus anticoagulants: results of The Second International Workshop for identification of lupus anticoagulants Thromb Haemost 74 1995 1597 1603
11. Jouhikainen T. Kekomaki R. Leirisalo-Repo M. Backlund T. Myllyla G. Platelet autoantibodies detected by immunoblotting in systemic lupus erythematosus: association with the lupus anticoagulant, and with history ofthrombosis and thrombocytopenia Eur J Haematol 44 1990 234 239
12. Fabris F. Cordiano I. Borzini P. Luzzatto G. Randi M.L. Specific antiplatelet antibodies in patients with antiphospholipid antibodies and thrombocytopenia Eur J Haemato1 53 1994 232 236
13. Delezé M. Alarcon-Segovia D. Oria C.M. SanchezGuerrero J. Fernandez-Dominguez L. Gomez-Pacheco L. Hemocytopenia in systemic lupus erythematosus: relationship to antiphospholipid antibodies J Rheumatol 16 1989 926 930
14. Sthoeger Z. Sthoeger D. Green L. Geltner D. The role of anticardiolipin autoanfibodies in the pathogenesis of autoimname hemolytic anemia in systemic lupus erythematosus J Rheumatol 20 1993 2058 2061
15. Pierre J.C. Wechsler B. Frances C. Papo T. Godeau P. Exclusion criteria for primary antiphospholipid syndrome J Rheumatol 20 1993 1802 1804
16. Spronk P.E. Limburg P.C. Kallenberg C.G. Serological markers of disease activity in systemic lupus erythematosus Lupus 4 1995 86 94
17. Cervera R. Asherson R.A. Lie J.T. Clinicopathologic correlations of the antiphospholipid syndrome Semin Arthritis Rheum 24 1995 262 272
18. Hughson M.D. Nadasdy T. McCarty G.A. Renal thrombotic microangiopathy in patients with systemic lupus erythematosus and the antiphospholipid syndrome Am J Kidney Dis 20 1992 150 158
19. Derksen R.H.W.M. Clinical manifestations and management of the antiphospholipid syndrome Lupus 5 1996 167 169
20. Shah N.M. Khamashta M.A. Atsumi T. Hughes G.R.V. Outcome of patients with anticardiolipin antibodies: a 10 year follow-up of 52 patients Lupus 7 1998 3 6
21. Rosove M.H. Brewer P.M.C. Antiphospholipid thrombosis: clinical course after the first thrombosic event in 70 patients Ann Intern Med 117 1992 303 308
22. Krnic-Barrie S. O'Connor C.R. Looney S.W. Pierangeli S.S. Harris E.N. A retrospective review of 61 patients with antiphospholipid syndrome: analysis of factors influencing recurrent thrombosis Arch Intern Med 157 1997 2101 2108
23. Khamashta M.A. Cuadrado M.J. Mujic F. Taub N.A. Hunt B.J. Hughes G.R.V. The management of thrombosis in the antiphospholipid-antibody syndrome N Engl J Med 332 1995 993 997
24. Insko E.K. Haskal Z.J. Antiphospholipid syndrome: patterns of life-threatening and severe recurrent vascular complications Radiology 202 1997 319 326
25. Wahl D.G. Guillemin F. De Maistre E. Perret-Guillaume C. Lecompte T. Thibaut G. Meta-analysis of the risk of venous thrombosis in individuals with antiphospholipid antibodies without underlying autoinunune disease or previousthrombosis Lupus 7 1998 15 22
26. Horbach D.A. V. Oort E. Donders R.C.J.M. Derksen R.H.W.M. de Groot P.G. Lupus anticoagulant is the strongest risk factor for both venous and arterial thrombosis in patients with systemic lupus erythematosus Thromb Haemost 76 1996 916 924
27. Della Valle P. Crippa L. Safa O. Tomassini L. Pattarini E. Vigano-D'Angelo S. Potential failure of the international normalized ratio (INR) system in the monitoring of oral anticoagulation in patients with lupusanticoagulants Ann Med Interne (Paris) 147 1996 10 14
28. Moll S. Ortel T.L. Monitoring warfarin therapy in patients with lupus anticoagulants Ann Intern Med 127 1997 177 185
29. Robert A. Le Querrec A. Delahousse B. Caron C. Houbouyan L. Boutière B. Control of oral anticoagulation in patients with the antiphospholipid syndrome: influence of the lupus anticoagulant on international normalized ratio Thromb Haemost 80 1998 99 103
30. Oshiro B.T. Silver R.M. Scott J.R. Yu H. Branch W. Antiphospholipid antibodies and fetal death Obstet Gynecol 87 1996 489 493
31. Cowchock F.S. Reece E.A. Balaban D. Branch D.W. Plouffe L. Repeated fetal losses associated with antiphospholipid antibodies: a collaborative randomized trial comparing prednisone to low-dose heparin treatment Am J Obstet Gynecol 166 1992 1318 1323
32. Granger K.A. Farquharson R.G. Obstetric outcome in antiphospholipid syndrome Lupus 6 1997 509 513
33. Rai R.S. Clifford K. Cohen H. Regan L. High prospective fetal loss rate in untreated pregnancies of women with recurrent miscarriage and antiphospholipid antibodies Hum Reprod 10 1995 3301 3304
34. Sthoeger Z.M. Mozes E. Tartakovsky B. Anticardiolipin antibodies induce pregnancy failure by impairing embryonic implantation Proc Natl Acad Sci USA 90 1993 6464 6467
35. Fishman P. Falach-Vaknine E. Zigelman R. Bakimer R. Sredni B. Djaldetti M. Prevention of fetal loss in experimental antiphospholipid syndrome by in vitro administration of recombinant interleukin-3 J Clin Invest 41 1993 1834 1837
36. Shurtz-Swirski R. Inbar O. Blank M. Cohen J. Bakimer R. Bamea E.R. In vitro effect of anticardiolipin antibodies upon total and pulsatile placental hCG secretion during early pregnancy Am J Reprod Immunol 29 1993 206 210
37. Lima F. Khamashta M.A. Buchanan N.M.M. Kerslake S. Hunt B.J. Hughes G.R.V. A study of sixty pregnancies in patients with the antiphospholipid syndrome Clin Exp Rheumatol 14 1996 131 136
38. Rai R. Cohen H. Dave M. Regan L. Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipidantibodies (or antiphospholipid antibodies) BMJ 314 1997 253 257
39. Kutteh W.H. Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone Am J Obstet Gynecol 174 1996 1584 1589